News Releases

Keyword Search

May-03-2021
Oncternal Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Apr-29-2021
Oncternal Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update
Apr-28-2021
Oncternal Therapeutics Announces Presentation of Two Abstracts at ASCO 2021 Virtual Meeting
Apr-12-2021
Oncternal Therapeutics Announces Appointment of Chase Leavitt as General Counsel
Apr-12-2021
Oncternal Therapeutics Announces Presentation of Three Posters at AACR 2021 Virtual Meeting
Mar-18-2021
Oncternal Therapeutics Reports Granting of an Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Mar-11-2021
Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2020 Financial Results
Mar-04-2021
Oncternal Therapeutics to Report Fourth Quarter 2020 Financial Results and Provide Business Update
Feb-24-2021
Oncternal Therapeutics to Participate in March Investor Conferences
Feb-22-2021
Oncternal Therapeutics Reports Granting of an Inducement Award Under Nasdaq Listing Rule 5635(c)(4)